CAS 1246770-52-4

N-[(1R)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide

Description:

N-[(1R)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide is a synthetic organic compound characterized by its complex structure, which includes multiple functional groups such as an amide, imidazole, and oxadiazole. This compound features a dichlorophenyl moiety, contributing to its potential biological activity, particularly in medicinal chemistry. The presence of the imidazole ring suggests possible interactions with biological targets, making it of interest in pharmacological research. The oxadiazole group may enhance the compound's stability and lipophilicity, influencing its bioavailability and pharmacokinetics. Its stereochemistry, indicated by the (1R) configuration, may also play a crucial role in its biological activity and interaction with receptors or enzymes. Overall, this compound's unique structural features position it as a candidate for further investigation in drug development, particularly in areas targeting specific diseases or conditions.

Formula: C₂₆H₁₉Cl₂N₅O₂

InChI: InChI=1S/C26H19Cl2N5O2/c27-20-10-11-21(22(28)14-20)23(15-33-13-12-29-16-33)30-24(34)17-6-8-19(9-7-17)26-32-31-25(35-26)18-4-2-1-3-5-18/h1-14,16,23H,15H2,(H,30,34)/t23-/m0/s1

InChI key: InChIKey=CJPLMXOWZZCYHJ-QHCPKHFHSA-N

SMILES: [C@@H](CN1C=CN=C1)(NC(=O)C2=CC=C(C=C2)C=3OC(=NN3)C4=CC=CC=C4)C5=C(Cl)C=C(Cl)C=C5

Synonyms:

• N-[(1R)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide
• Benzamide, N-[(1R)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)-
• VNI

VNI

CAS: 1246770-52-4

VNI is a potent anticancer compound that inhibits the growth of tumors by targeting specific kinases involved in cancer cell cycle regulation. It is a medicinal compound that has been extensively studied for its ability to induce apoptosis in cancer cells. VNI works by blocking the activity of specific kinases, which are essential for cancer cell survival and proliferation. This inhibitor has been shown to be effective against a wide range of cancers, including Chinese hamster ovary and human cancer cell lines. VNI is an analog of protein kinase inhibitors and has been found to have high selectivity towards cancer cells, while sparing healthy cells. Its ability to induce apoptosis makes it a promising candidate for cancer therapy.

Formula: C₂₆H₁₉Cl₂N₅O₂

Purity: Min. 95%

Molecular weight: 504.4 g/mol

Ref: 3D-WZB77052

VNI

CAS: 1246770-52-4

VNI is an effective inhibitor of CYP51. It suppresses sterol synthesis in Trypanosoma cruzi, exhibiting anti-Trypanosoma cruzi activity.

Formula: C₂₆H₁₉Cl₂N₅O₂

Color and Shape: Solid

Molecular weight: 504.37

Ref: TM-T201793